These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases. Talbird SE, Graham J, Mauskopf J, Masseria C, Krishnarajah G. J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776 [Abstract] [Full Text] [Related]
11. Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis. Cho BH, Acosta AM, Leidner AJ, Faulkner AE, Zhou F. Prev Med; 2020 May; 134():106066. PubMed ID: 32199910 [Abstract] [Full Text] [Related]
17. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV, Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 2006 Mar 24; 55(RR-3):1-34. PubMed ID: 16557217 [Abstract] [Full Text] [Related]
18. Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study. Sancovski M, Mesaros N, Feng Y, Ceregido MA, Luyts D, De Barros E. Hum Vaccin Immunother; 2019 Mar 24; 15(12):2873-2881. PubMed ID: 31216218 [Abstract] [Full Text] [Related]
19. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis. Kandeil W, van den Ende C, Bunge EM, Jenkins VA, Ceregido MA, Guignard A. Expert Rev Vaccines; 2020 Jul 24; 19(7):621-638. PubMed ID: 32772755 [Abstract] [Full Text] [Related]
20. Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil. de Soárez PC, Sartori AM, Freitas AC, Nishikawa ÁM, Novaes HM. PLoS One; 2015 Jul 24; 10(6):e0130217. PubMed ID: 26114297 [Abstract] [Full Text] [Related] Page: [Next] [New Search]